How soluble GARP enhances TGF β activation

PLoS ONE

Volumn 11, Issue 4, 2016, Pages

  Fridrich, Sven ^a   Hahn, Susanne A ^b   Linzmaier, Marion ^a   Felten, Matthias ^a   Zwarg, Jenny ^b   Lennerz, Volker ^b   Tuettenberg, Andrea ^b   Stöcker, Walter ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHAVBETA6 INTEGRIN; ALPHAVBETA8 INTEGRIN; CELL SURFACE RECEPTOR; GLYCOPROTEIN A REPETITIONS PREDOMINANT; INTEGRIN; PROTEIN VARIANT; RECOMBINANT PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; LRRC32 PROTEIN, HUMAN; MEMBRANE PROTEIN;

ARTICLE; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; CYTOKINE RELEASE; DISULFIDE BOND; EMBRYO; HEK293 CELL LINE; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; PROTEIN STABILITY; REGULATORY T LYMPHOCYTE; TARGET CELL; CELL PROLIFERATION; CHEMISTRY; CIRCULAR DICHROISM; GENETICS; METABOLISM; MOLECULAR CLONING; PROTEIN CONFORMATION;

CELL PROLIFERATION; CIRCULAR DICHROISM; CLONING, MOLECULAR; HEK293 CELLS; HUMANS; MEMBRANE PROTEINS; PROTEIN CONFORMATION; RECOMBINANT PROTEINS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84963726185     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0153290     Document Type: Article

References (31)

1. Massagué J, Xi Q. TGF-β control of stem cell differentiation genes. FEBS Lett. 2012; 586: 1953-1958. doi:10.1016/j.febslet.2012.03.023PMID: 22710171.
2. Kulkarni a B, Huh CG, Becker D, Geiser a, Lyght M, Flanders KC, et al. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci U S A. 1993; 90: 770-774. PMID: 8421714.
3. Kehrl BYJH, Wakefield LM, Roberts AB, Jakowlew S, Alvarez-mon M, Derynck RIK, et al. Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med. 1986; 163: 1037-1050. PMID: 2871125.
4. Robertson IB, Rifkin DB. Unchaining the beast; insights from structural and evolutionary studies on TGF beta secretion, sequestration, and activation. Cytokine and Growth Factor Reviews. 2013. pp. 355-372. doi:10.1016/j.cytogfr.2013.06.003PMID: 23849989.
5. Macaulay IC, Tijssen MR, Thijssen-timmer DC, Gusnanto A, Steward M, Burns P, et al. Comparative gene expression profiling of in vitro differentiated megakaryocytes and erythroblasts identifies novel activatory and inhibitory platelet membrane proteins. Blood. 2007; 3260-3269. doi:10.1182/blood-2006-07-036269 PMID: 17192395.
6. Wang R, Wan Q, Kozhaya L, Fujii H, Unutmaz D. Identification of a Regulatory T Cell Specific Cell Surface Molecule that Mediates Suppressive Signals and Induces Foxp3 Expression. PLoS One. 2008; 3: 1-9. doi:10.1371/journal.pone.0002705.
7. Li Y, Kim B-G, Qian S, Letterio JJ, Fung JJ, Lu L, et al. Hepatic Stellate Cells Inhibit T Cells through Active TGF-β1 from a Cell Surface-Bound Latent TGF- 1/GARP Complex. J Immunol. 2015; doi:10.4049/jimmunol.1500139.
8. Ollendorff V, Noguchi T, Delapeyriere O, Birnbaum D. The GARP Gene Encodes a New Member of the Family of Leucine-rich Repeat-containing Proteins. Cell Growth Differ. 1994; 5: 213-219. PMID:8180135.
9. Kobe B, Deisenhofer J. Proteins with leucine-rich repeats. Curr Opin Struct Biol. 1995; 5: 409-416. doi10.1016/0959-440X(95)80105-7 PMID: 7583641.
10. Probst-Kepper M, Geffers R, Kröger A, Viegas N, Erck C, Hecht H, et al. GARP: A key receptor controlling FOXP3 in human regulatory T cells. J Cell Mol Med. 2009; 13: 3343-3357. doi:10.1111/j.1582-4934.2009.00782.x PMID: 19453521.
11. Stockis J, Colau D, Coulie PG, Lucas S. Membrane protein GARP is a receptor for latent TGF-beta on the surface of activated human Treg. Eur J Immunol. 2009; 39: 3315-3322. doi:10.1002/eji.200939684 PMID: 19750484.
12. Tran DQ, Andersson J, Wang R, Ramsey H, Unutmaz D, Shevach EM. GARP (LRRC32) is essential for the surface expression of latent TGF-beta on platelets and activated FOXP3(+) regulatory T cells. Proc Natl Acad Sci. 2009; 106: 13445-13450. doi:10.1073/pnas.0901944106PMID: 19651619.
13. Wildin RS, Ramsdell F, Peake J, Faravelli F, Casanova JL, Buist N, et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet. 2001; 27: 18-20. doi:10.1038/83707 PMID: 11137992.
14. Wang R, Kozhaya L, Mercer F, Khaitan A, Fujii H, Unutmaz D. Expression of GARP selectively identifies activated human FOXP3(+) regulatory T cells. Proc Natl Acad Sci. 2009; 106: 13439-13444. doi:10.1073/pnas.0901965106PMID: 19666573.
15. D'Alise AM, Ergun A, Hill J a, Mathis D, Benoist C. A cluster of coregulated genes determines TGFbeta- induced regulatory T cell (Treg) dysfunction in NOD mice. Proc Natl Acad Sci U S A. 2011; 108: 8737-42. doi:10.1073/pnas.1105364108PMID: 21543717.
16. Suarez-Pinzon WL, Marcoux Y, Ghahary A, Rabinovitch A. Gene transfection and expression of transforming growth factor-beta1 in nonobese diabetic mouse islets protects beta-cells in syngeneic islet grafts from autoimmune destruction. Cell Transplant. 2002; 11: 519-528. PMID: 12428741.
17. Card CM, McLaren PJ, Wachihi C, Kimani J, Plummer FA, Fowke KR. Decreased immune activation in resistance to HIV-1 infection is associated with an elevated frequency of CD4(+)CD25(+)FOXP3(+) regulatory T cells. J Infect Dis. 2009; 199: 1318-1322. doi:10.1086/597801 PMID: 19301980.
18. Miller MM, Fogle JE, Ross P, Tompkins MB. Feline glycoprotein A repetitions predominant anchors transforming growth factor beta on the surface of activated CD4(+)CD25(+) regulatory T cells and mediates AIDS lentivirus-induced T cell immunodeficiency. AIDS Res Hum Retroviruses. 2013; 29: 641-51. doi:10.1089/aid.2012.0322PMID: 23373523.
19. Kalathil S, Lugade A a, Miller A, Iyer R, Thanavala Y. Higher frequencies of GARP(+)CTLA-4(+)Foxp3 (+) T regulatory cells and myeloid-derived suppressor cells in hepatocellular carcinoma patients are associated with impaired T cell functionality. Cancer Res. 2013; 73: 2435-44. doi:10.1158/0008-5472. CAN-12-3381 PMID: 23423978.
20. Kanzaki T, Olofsson A, Morén A, Wernstedt C, Hellman U, Miyazono K, et al. TGF-beta 1 binding protein: A component of the large latent complex of TGF-beta 1 with multiple repeat sequences. Cell. 1990;61: 1051-1061. PMID: 2350783.
21. Wang R, Zhu J, Dong X, Shi M, Lu C, Springer TA. GARP regulates the bioavailability and activation of TGF-beta. Mol Biol Cell. 2012; 23: 1129-1139. doi:10.1091/mbc.E11-12-1018PMID: 22278742.
22. Oida T, Weiner HL. Murine CD4 T cells produce a new form of TGF as measured by a newly developed TGF-beta bioassay. PLoS One. 2011; 6. doi:10.1371/journal.pone.0018365.
23. Gauthy E, Cuende J, Stockis J, Huygens C, Lethé B, Collet J-F, et al. GARP Is Regulated by miRNAs and Controls Latent TGF-β1 Production by Human Regulatory T Cells. PLoS One. 2013; 8: E76186. doi:10.1371/journal.pone.0076186 PMID: 24098777.
24. Hahn SA, Stahl HF, Becker C, Correll A, Schneider F-J, Tuettenberg A, et al. Soluble GARP has potent antiinflammatory and immunomodulatory impact on human CD4+ T cells. Blood. 2013; 122: 1182-91. doi:10.1182/blood-2012-12-474478 PMID: 23818544.
25. Absher M, Baldor L, Kelley J. A rapid colorimetric bioassay for transforming growth factor beta using a microwell plate reader. J Immunol Methods. 1991; 138: 301-303. doi:10.1016/0022-1759(91)90179-J PMID: 2033282.
26. Lennerz V, Fatho M, Gentilini C, Frye R a, Lifke A, Ferel D, et al. The response of autologous T cells to a human melanoma is dominated by mutated neoantigens. Proc Natl Acad Sci U S A. 2005; 102: 16013-16018. doi:10.1073/pnas.0500090102 PMID: 16247014.
27. Wu F, Buckley S, Bui KC, Yee A, Wu HY, Liu J, et al. Cell cycle arrest in G0/G1 phase by contact inhibition and TGF-beta 1 in mink Mv1Lu lung epithelial cells. Am J Physiol. 1996; L879-L888 PMID: 8967524.
28. McMahon GA, Dignam JD, Gentry LE. Structural characterization of the latent complex between transforming growth factor beta 1 and beta 1-latency-associated peptide. Biochem J. 1996; 313: 343-351. PMID: 8546705.
29. Becker C, Kruse M-N, Slotty K a, Köhler D, Harris JR, Rösmann S, et al. Differences in the activation mechanism between the alpha and beta subunits of human meprin. Biol Chem. 2003; 384: 825-831. doi:10.1515/BC.2003.092PMID: 12817480.
30. Buscemi L, Ramonet D, Klingberg F, Formey A, Smith-Clerc J, Meister J-J, et al. The single-molecule mechanics of the latent TGF-β1 complex. Curr Biol. 2011; 21: 2046-54. doi:10.1016/j.cub.2011.11.037 PMID: 22169532.
31. Probst-Kepper M, Kröger A, Garritsen SP, Buer J. Perspectives on Regulatory T Cell Therapies. 2009; 302-308. doi:10.1159/000235929.